What new Dupilumab data suggest about long-term immune control in allergic disease at Regeneron Pharmaceuticals
Ryerson Holding (NYSE: RYI) finalises Olympic Steel acquisition as North American metals consolidation accelerates
Vikran Engineering (NSE: VIKRAN) Q3 FY26 results show solar-led order book surge as margins reset during execution ramp-up
Ducon Infratechnologies (NSE: DUCON) Q3 FY26 results signal margin pressure even as carbon capture and AI bets move closer to execution
Read More 8 minute read General business news Enviri Corporation company profile: Business model, financials, and growth outlook (2026 edition) Enviri Corporation company profile covering business model, revenue FY2025, strategic sale of Clean Earth, and 2026–2027 growth outlook and stock perspective. bySrinathFebruary 2, 2026